Anavex Life Sciences Corp (AVXL)

[falconer66a]

Let watch, by the end of 2023.

2 Years out this company, should it survive its independence, with continued positive endpoint outcomes will become a bohemouth,imo.

My evidence-based “opinion,” too.

Some number of years ago, after scrutinizing (and understanding) the deep biological science of blarcamesine (Anavex 2-73) revealed in the many preclinical murine (lab rodent) and early human studies, I determined that Anavex Life Sciences would probably achieve significant annual revenues starting in 2023; would take that long to complete the human trials required for FDA approval(s), etc.

I got the most of my AVXL shares below $3.00. I’ve had to presume that those invested funds would be, until 2023, “dead money,” not available to invest in anything with more immediate rewards. But, with an average cost basis of $2.67 for my several thousand AVXLs, I can presently take some delight in my 599% value gain. But far greater by the end of 2023. Then, on out....?

Anavex for over five years, has been just "dead money," beating all of the ETFs and general market gains. By the end of 2023, two years from now, it will be "live money." Pretty good, either way.